ISOLATION OF ARABINOSE FROM A MIXTURE OF ARABINOSE AND XYLOSE VIA THEIR N-P-NITROPHENYLGLYCOSYLAMINESBILIK V; KRAMAR A.1979; CHEM. ZVESTI; CSK; DA. 1979; VOL. 33; NO 5; PP. 641-644; ABS. RUS; BIBL. 10 REF.Article

UNTERSUCHUNGEN DER SAUREN FUNKTIONELLEN GRUPPEN VERSCHIEDENER 4-O-METHYLGLUKURONOXYLANPRAEPARATE = ETUDE DES GROUPES FONCTIONNELS ACIDES DE DIFFERENTES PREPARATIONS D'O-METHYL-4 GLUCURONOXYLANEEBRINGEROVA A; KRAMAR A.1975; CHEM. ZVESTI; CESKOSL.; DA. 1975; VOL. 29; NO 1; PP. 104-109; ABS. ANGL.; BIBL. 27 REF.Article

DEGRADATION THERMIQUE DES HEMICELLULOSES DE FEUILLUS AUX TEMPERATURES DE 80 A 120^OC. V. INFLUENCE DE L'HUMIDITE SUR LA STABILITE THERMIQUE DU 4-0-METHYLGLUCURONOXYLANE DANS L'AZOTE ET DANS L'AIREBRINGEROVA A; KRAMAR A.1976; PAPIR A CELULOZA; CESKOSL.; DA. 1976; VOL. 31; NO 7-8; PP. V31-V34; ABS. ANGL. ALLEM. RUSSE; BIBL. 11 REF.Article

DEGRADATION THERMIQUE DES HEMICELLULOSES DE FEUILLUS AUX TEMPERATURES DE 80 A 200^OC. IV. STABILITE THERMIQUE DU 4-0-METHYLGLUCURONOXYLANE DANS UNE ATMOSPHERE D'AIR SECEBRINGEROVA A; KRAMAR A.1976; PAPIR A CELULOZA; CESKOSL.; DA. 1976; VOL. 31; NO 7-8; PP. V27-V30; ABS. ANGL. ALLEM. RUSSEArticle

STRUCTURE ET COMPOSITION CHIMIQUE DE L'ECORCE DE HETREKRAMAR A; ZAKUTNA L; EBRINGEROVA A et al.1977; PAPIR A CELLULOZA; CESKOSL.; DA. 1977; VOL. 32; NO 11; PP. V57-V66 (7P.); ABS. ANGL. ALLEM. RUSSE; BIBL. 39 REF.Article

CURE RATE ESTIMATION AND LONG TERM PROGNOSIS OF UTERINE CERVIX CARCINOMAPEJOVIC MH; WOLFF JP; KRAMAR A et al.1981; CANCER; ISSN 0008-543X; USA; DA. 1981; VOL. 47; NO 1; PP. 203-206; BIBL. 16 REF.Article

EVOLUTION A LONG TERME DES CANCERS DU COL DE L'UTERUSPEJOVIC MH; WOLFF JP; THUAIRE M et al.1980; BULL. CANCER; FRA; DA. 1980; VOL. 67; NO 1; PP. 93Article

ESSAI COMPARATIF RANDOMISE D'UN NOUVEL ANTI-EMETIQUE: LA NABILONE, CHEZ DES MALADES CANCEREUSES TRAITEES PAR LE CIS-PLATINUM = A COMPARATIVE RANDOMIZED TRIAL OF A NEW ANTIEMETIC COMPOUND: NABILONE IN CANCER FEMALES PATIENTS TREATED WITH CIS-PLATINUMGEORGE M; PEJOVIC MH; THUAIRE M et al.1983; BIOMEDICINE AND PHARMACOTHERAPY; ISSN 0753-3322; FRA; DA. 1983; VOL. 37; NO 1; PP. 24-27; ABS. ENG/FRE; BIBL. 15 REF.Article

ANALYZA A VYUZITIE HEMICELULOZ ODPADOVYCH LUHOV Z VYROBY VISKOZY = ANALYSE ET UTILISATION DES HEMICELLULOSES DES BASES RESIDUAIRES DE FABRICATION DE LA VISCOSEEBRINGEROVA A; KRAMAR A; SIMKOVIC I et al.1980; CHEM. VLAKNA; ISSN 0528-9432; CSK; DA. 1980; VOL. 30; NO 4; PP. 198-206; ABS. RUS/ENG; BIBL. 18 REF.Article

Continual reassessment methods in phase I trials of the combination of two drugs in oncologyKRAMAR, A; LEBECQ, A; CANDALH, E et al.Statistics in medicine. 1999, Vol 18, Num 14, pp 1849-1864, issn 0277-6715Conference Paper

Four-step high-dose sequential chemotherapy with hematopoietic progenitor-cell support as induction treatment for patients with solid tumorsCULINE, S; FABBRO, M; ASSENS, C et al.Annals of oncology. 1997, Vol 8, Num 10, pp 951-956, issn 0923-7534Article

High-dose chemotherapy as salvage treatment in germ cell tumors : A multivariate analysis of prognostic variablesBEYER, J; KRAMAR, A; NICHOLS, C. R et al.Journal of clinical oncology. 1996, Vol 14, Num 10, pp 2638-2645, issn 0732-183XArticle

High failure rate of carbonplatin-etoposide combination in good risk non-seminomatous germ cell tumoursKATTAN, J; MONDER MAHJOUBI; DROZ, J.-P et al.European journal of cancer. Part A. 1993, Vol 29, Num 11, pp 1504-1509Article

Prediction of long-term response after high-dose chemotherapy with autologous bone marrow transplantation in the salvage treatment of non-seminomatous germ cell tumoursDROZ, J.-P; KRAMAR, A; PICO, J.-L et al.European journal of cancer. Part A. 1993, Vol 29, Num 6, pp 818-821Article

Prognostic factors in metastatic diseaseDROZ, J.-P; KRAMAR, A; REY, A et al.Seminars in oncology. 1992, Vol 19, Num 2, pp 181-189, issn 0093-7754Article

Consumption of dairy produce and alcohol in a case-control study of breast cancerLE, M. G; MOULTON, L. H; HILL, C et al.Journal of the National Cancer Institute. 1986, Vol 77, Num 3, pp 633-636, issn 0027-8874Article

Analyse des résultats d'un essai utilisant le sujet comme son propre témoin avec un critère de jugement binaire = Analysis of binary response cross-over clinical trialsPEJOVIC, M. H; REY, A; KRAMAR, A et al.Journal de pharmacologie. 1986, Vol 17, Num 4, pp 497-507, issn 0021-793XArticle

Tumor marker kinetics predict outcome in patients with relapsed disseminated non-seminomatous germ-cell tumorsMASSARD, C; KRAMAR, A; BEYER, J et al.Annals of oncology. 2013, Vol 24, Num 2, pp 322-328, issn 0923-7534, 7 p.Article

Efficacy of irinotecan in combination with 5-fluorouracil (FOLFIRI) for metastatic gastric or gastroesophageal junction adenocarcinomas (MGA) treatmentSAMALIN, E; AFCHAIN, P; BOUCHE, O et al.Clinics and research in hepatology and gastroenterology (Print). 2011, Vol 35, Num 1, pp 48-54, issn 2210-7401, 7 p.Article

Refining the optimal chemotherapy regimen for good-risk metastatic nonseminomatous germ-cell tumors : a randomized trial of the Genito-Urinary Group of the French Federation of Cancer Centers (GETUG T93BP)CULINE, S; KERBRAT, P; BIRON, P et al.Annals of oncology. 2007, Vol 18, Num 5, pp 917-924, issn 0923-7534, 8 p.Article

Potentiation of ionising radiation by targeting tumour necrosis factor alpha using a bispecific antibody in human pancreatic cancerAZRIA, D; LARBOURET, C; GARAMBOIS, V et al.British journal of cancer. 2003, Vol 89, Num 10, pp 1987-1994, issn 0007-0920, 8 p.Article

Statistical optimisation of diclofenac sustained release pellets coated with polymethacrylic filmsKRAMAR, A; TURK, S; VRECER, F et al.International journal of pharmaceutics. 2003, Vol 256, Num 1-2, pp 43-52, issn 0378-5173, 10 p.Conference Paper

Non-parametric methods for analysing recurrent complications of varying severityLANCAR, R; KRAMAR, A; HAIE-MEDER, C et al.Statistics in medicine. 1995, Vol 14, Num 24, pp 2701-2712, issn 0277-6715Article

Early intensified chemotherapy with autologous bone marrow transplantation in first line treatment of poor risk non-seminomatous germ cell tumours : preliminary results of a French randomized trial. DiscussionCHEVREAU, C; DROZ, J. P; BOUZY, J et al.CHEVREAU, C; European urology. 1993, Vol 23, Num 1, pp 213-218, issn 0302-2838Conference Paper

Competing events determining relapse-free survival in limited small-cell lung carcinomaARRIAGADA, R; KRAMAR, A; LE CHEVALIER, T et al.Journal of clinical oncology. 1992, Vol 10, Num 3, pp 447-451, issn 0732-183XArticle